Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 81
- 較 2023 年第 2 季 0
- 總值
- $2.69 億
- 較 2023 年第 2 季 −$1,413 萬 (−5.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SLRNACELYRIN, Inc. | COM | 2,918,426 | $2,968 萬 | 11.0% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 792,920 | $2,358 萬 | 8.8% | +317,920+66.9% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 536,720 | $1,584 萬 | 5.9% | +536,720 | 新進 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 654,726 | $1,342 萬 | 5.0% | +654,726 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 278,034 | $1,278 萬 | 4.7% | +5,282+1.9% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 473,126 | $1,248 萬 | 4.6% | +43,440+10.1% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 297,794 | $1,143 萬 | 4.2% | +297,794 | 新進 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 200,000 | $1,012 萬 | 3.8% | +200,000 | 新進 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 518,519 | $921.4 萬 | 3.4% | +518,519 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 142,417 | $726.0 萬 | 2.7% | +2,417+1.7% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 137,824 | $694.9 萬 | 2.6% | +137,824 | 新進 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 142,766 | $670.7 萬 | 2.5% | −97,265−40.5% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 174,945 | $623.7 萬 | 2.3% | +53,287+43.8% | 加碼 | 歷史 |
| IMGNImmunoGen, Inc. | COM | 390,162 | $619.2 萬 | 2.3% | −57,538−12.9% | 減碼 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 746,069 | $600.6 萬 | 2.2% | +134,137+21.9% | 加碼 | 歷史 |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 505,862 | $591.4 萬 | 2.2% | +505,862 | 新進 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 216,949 | $585.3 萬 | 2.2% | −273,944−55.8% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 1,254,384 | $490.5 萬 | 1.8% | +275,758+28.2% | 加碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 254,876 | $457.5 萬 | 1.7% | −25,124−9.0% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 178,360 | $412.4 萬 | 1.5% | +178,360 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 154,900 | $391.1 萬 | 1.5% | −330,100−68.1% | 減碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 2,250,000 | $384.8 萬 | 1.4% | +2,250,000 | 新進 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 346,471 | $379.4 萬 | 1.4% | +346,471 | 新進 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 865,787 | $323.8 萬 | 1.2% | +865,787 | 新進 | 歷史 |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 514,101 | $285.8 萬 | 1.1% | +9,848+2.0% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 374,807 | $279.6 萬 | 1.0% | −204,583−35.3% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 106,138 | $276.1 萬 | 1.0% | −321,279−75.2% | 減碼 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 682,868 | $269.7 萬 | 1.0% | +682,868 | 新進 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 305,857 | $237.0 萬 | 0.9% | +5,857+2.0% | 加碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 688,604 | $205.2 萬 | 0.8% | +688,604 | 新進 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,579,770 | $200.6 萬 | 0.7% | +1,529,770+3,059.5% | 加碼 | 歷史 |
| ALLKAllakos Inc. | COM | 787,056 | $178.7 萬 | 0.7% | +14,964+1.9% | 加碼 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 1,737,636 | $170.3 萬 | 0.6% | +32,031+1.9% | 加碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 1,222,852 | $163.9 萬 | 0.6% | +1,222,852 | 新進 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 555,572 | $159.4 萬 | 0.6% | +10,469+1.9% | 加碼 | 歷史 |
| BIVIBiovie Inc. | CL A NEW | 457,345 | $156.0 萬 | 0.6% | +8,789+2.0% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 104,300 | $155.5 萬 | 0.6% | +104,300 | 新進 | 歷史 |
| AEONAEON Biopharma, Inc. | CL A | 257,977 | $144.5 萬 | 0.5% | +257,977 | 新進 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 462,828 | $143.5 萬 | 0.5% | +2,412+0.5% | 加碼 | 歷史 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 30,546 | $138.6 萬 | 0.5% | +30,546 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 142,692 | $137.4 萬 | 0.5% | +2,692+1.9% | 加碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 195,899 | $132.0 萬 | 0.5% | +3,639+1.9% | 加碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 315,265 | $130.8 萬 | 0.5% | −339,680−51.9% | 減碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 229,100 | $120.0 萬 | 0.4% | +229,100 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 718,259 | $110.6 萬 | 0.4% | +584,113+435.4% | 加碼 | 歷史 |
| QUREuniQure N.V. | SHS | 157,365 | $105.6 萬 | 0.4% | +157,365 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 853,391 | $101.6 萬 | 0.4% | +11,795+1.4% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 165,480 | $83.2 萬 | 0.3% | −150,000−47.5% | 減碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM | 1,125,087 | $78.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 1,171,939 | $77.7 萬 | 0.3% | +22,449+2.0% | 加碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 48,170 | $66.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 450,000 | $66.2 萬 | 0.2% | −200,000−30.8% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 1,227 | $65.9 萬 | 0.2% | +1,227 | 新進 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 472,625 | $61.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 262,694 | $61.2 萬 | 0.2% | +2,607+1.0% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 62,766 | $61.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMTXImmatics N.V. | SHS | 49,031 | $56.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| KODKodiak Sciences Inc. | COM | 312,881 | $56.3 萬 | 0.2% | +250,354+400.4% | 加碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 400,000 | $53.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 157,862 | $50.4 萬 | 0.2% | +1,659+1.1% | 加碼 | 歷史 |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,765,530 | $49.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 530,776 | $32.7 萬 | 0.1% | −69,224−11.5% | 減碼 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 188,664 | $31.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 32,547 | $27.2 萬 | 0.1% | +32,547 | 新進 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 10,862 | $24.3 萬 | 0.1% | +10,862 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 318,591 | $21.4 萬 | 0.1% | +4,914+1.6% | 加碼 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 591,676 | $19.1 萬 | 0.1% | −300,000−33.6% | 減碼 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 213,392 | $19.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 18,647 | $13.3 萬 | <0.1% | −131,353−87.6% | 減碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 40,369 | $12.1 萬 | <0.1% | −25,122−38.4% | 減碼 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 15,292 | $7.65 萬 | <0.1% | +292+1.9% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 21,590 | $6.78 萬 | <0.1% | −78,410−78.4% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,000 | $5.81 萬 | <0.1% | +4,000 | 新進 | 歷史 |
| SYBXSynlogic, Inc. | COM NEW | 20,448 | $5.75 萬 | <0.1% | 00.0% | 不變依 1 比 15 拆股換算 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 12,116 | $4.77 萬 | <0.1% | −58,274−82.8% | 減碼 | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM NEW | 6,892 | $3.51 萬 | <0.1% | −1,025−12.9% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,821 | $2.13 萬 | <0.1% | −223,179−99.2% | 減碼 | 歷史 |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 90,242 | $1.81 萬 | <0.1% | −99,693−52.5% | 減碼 | 歷史 |
| Aslan Pharmaceuticals Ltd04522R200 | SPON ADS NEW | 35,420 | $6,215 | <0.1% | −128,668−78.4% | 減碼 | – |
| KYNBKyntra Bio, Inc. | COM | 2,774 | $2,393 | <0.1% | −225,646−98.8% | 減碼 | 歷史 |
| Phaxiam Therapeutics S A29604W207 | SPON ADR NEW | 301 | $1,558 | <0.1% | +301 | 新進 | – |
選擇權（43 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SRPTSarepta Therapeutics, Inc. | COM | $4,452 萬 | $2,574 萬 |
| SPYSPDR S&P 500 ETF Trust | ETF | $6,412 萬 | – |
| IMVTImmunovant, Inc. | COM | $2,125 萬 | $2,776 萬 |
| Invesco QQQ Trust Series I46090E103 | ETF | $4,299 萬 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $3,651 萬 | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | $1,351 萬 | $1,206 萬 |
| AKROAkero Therapeutics, Inc. | COM | $1,542 萬 | $1,006 萬 |
| MRNAModerna, Inc. | Stock | $2,523 萬 | – |
| ABBVAbbVie Inc. | Stock | – | $1,975 萬 |
| SNDXSyndax Pharmaceuticals Inc | COM | $1,089 萬 | $363.0 萬 |
| NVAXNovavax Inc | COM NEW | $878.4 萬 | $516.4 萬 |
| NUVLNuvalent, Inc. | COM | $240.4 萬 | $1,101 萬 |
| REPLReplimune Group, Inc. | COM | $930.4 萬 | $397.8 萬 |
| CYTKCytokinetics Inc | COM NEW | $599.5 萬 | $599.5 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | $156.7 萬 | $899.6 萬 |
| KRYSKrystal Biotech, Inc. | COM | $980.2 萬 | – |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | $925.5 萬 | $17.7 萬 |
| BMRNBiomarin Pharmaceutical Inc | COM | $900.7 萬 | – |
| IRONDisc Medicine, Inc. | COM | $716.9 萬 | $133.4 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | – | $805.3 萬 |
| RCUSArcus Biosciences, Inc. | COM | – | $718.0 萬 |
| ACRSAclaris Therapeutics, Inc. | COM | $407.9 萬 | $249.1 萬 |
| VERVVerve Therapeutics, Inc. | COM | $320.0 萬 | $265.2 萬 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | – | $567.2 萬 |
| IMGNImmunoGen, Inc. | COM | – | $566.2 萬 |
| RVMDRevolution Medicines, Inc. | COM | $563.3 萬 | – |
| JAZZJazz Pharmaceuticals plc | SHS USD | – | $541.1 萬 |
| ETNB89bio, Inc. | COM | – | $541.0 萬 |
| CBAYCymaBay Therapeutics, Inc. | COM | $121.7 萬 | $332.5 萬 |
| VTYXVentyx Biosciences, Inc. | COM | $428.2 萬 | – |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $378.1 萬 |
| EYPTEyePoint, Inc. | COM NEW | $358.5 萬 | – |
| ITOSiTeos Therapeutics, Inc. | COM | – | $334.6 萬 |
| RCKTRocket Pharmaceuticals, Inc. | COM | – | $307.4 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $267.2 萬 | – |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | – | $248.6 萬 |
| DYNDyne Therapeutics, Inc. | COM | – | $244.2 萬 |
| SLRNACELYRIN, Inc. | COM | – | $139.2 萬 |
| TERNTerns Pharmaceuticals, Inc. | COM | – | $100.6 萬 |
| MORFMorphic Holding, Inc. | COM | $29.6 萬 | $3.21 萬 |
| STOKStoke Therapeutics, Inc. | COM | – | $19.7 萬 |
| XENEXenon Pharmaceuticals Inc. | COM | $3.76 萬 | – |
| INSMINSMED Inc | COM PAR $.01 | – | $5,050 |
2023 年第 2 季之後清倉（24 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 133,800 | $1,219 萬 | 4.3% | 歷史 |
| MRKMerck & Co., Inc. | Stock | 100,000 | $1,154 萬 | 4.1% | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 275,875 | $605.5 萬 | 2.1% | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 135,486 | $521.6 萬 | 1.8% | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 203,037 | $518.2 萬 | 1.8% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 130,000 | $463.6 萬 | 1.6% | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 174,510 | $245.7 萬 | 0.9% | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 200,163 | $207.6 萬 | 0.7% | 歷史 |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 160,200 | $177.2 萬 | 0.6% | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 25,000 | $172.6 萬 | 0.6% | 歷史 |
| MRUSMerus N.V. | COM | 63,125 | $166.2 萬 | 0.6% | 歷史 |
| BLUEbluebird bio, Inc. | COM | 412,628 | $135.8 萬 | 0.5% | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM | 155,819 | $102.2 萬 | 0.4% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 35,000 | $96.7 萬 | 0.3% | 歷史 |
| ARDXArdelyx, Inc. | COM | 278,825 | $94.5 萬 | 0.3% | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 349,133 | $67.7 萬 | 0.2% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 5,472 | $55.8 萬 | 0.2% | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 221,830 | $30.4 萬 | 0.1% | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 28,784 | $26.1 萬 | 0.1% | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | ADS | 219,501 | $24.4 萬 | 0.1% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 2,090 | $18.7 萬 | 0.1% | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 283,464 | $13.0 萬 | <0.1% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 75 | $1.73 萬 | <0.1% | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 3,019 | $2,257 | <0.1% | – |